Phreesia, Inc. (PHR)
Healthcare · NYQ · US
Price as at 30 Sept 2026, 23:37 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Phreesia, Inc. trades at $10.33, which is 33% above the $6.93 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.
Our moat model scores it 47 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 55.6 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
PHR earnings and analyst estimates
Recommendation mix, 18 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Phreesia, Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
PHR passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Super investor ownership
8 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$32.43M · 0.0% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$5.40M · 0.0% of book
- Steve Cohen, Point72 Asset Management, L.P.$4.98M · 0.0% of book
- Ken Griffin, CITADEL ADVISORS LLC$4.42M · 0.0% of book
- Paul Tudor Jones, TUDOR INVESTMENT CORP ET AL$3.50M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Politician trades in PHR
We hold 8 disclosed trades in PHR by members of Congress and executive-branch officials. The latest 5:
- Gilbert Cisneros · HouseSell · $1,001 - $15,000 · traded 26 Aug 2026 · disclosed 10 Sept 2026
- Gilbert Cisneros · HouseSell · $1,001 - $15,000 · traded 25 Aug 2026 · disclosed 10 Sept 2026
- Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 9 Oct 2025 · disclosed 18 Nov 2025
- Gilbert Cisneros · HouseSell · $1,001 - $15,000 · traded 23 Dec 2020 · disclosed 11 Jan 2021
- Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 27 Oct 2020 · disclosed 5 Nov 2020
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
PHR peers
The largest companies in the same industry (Health Information Services), then in the same sector.
- PME.AX Pro Medicus Limited
- HNGE Hinge Health, Inc.
- WAY Waystar Holding Corp.
- PRVA Privia Health Group, Inc.
- HTFL Heartflow, Inc.
- OMCL Omnicell, Inc.
- CERT Certara, Inc.
- TALK Talkspace, Inc.
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is Phreesia, Inc. (PHR) undervalued?
Against our fair value estimate of $6.93, PHR at $10.33 is 33% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Which funds own PHR?
8 of the institutions we track reported a position in PHR in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
What is PHR's P/E ratio?
PHR trades at 55.6 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
Where does SteadyShares get its PHR data?
Fundamentals for PHR come from company filings and exchange data, as listed on NYQ; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 23:37 UTC and is delayed. Our data quality score for this company is 96/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for PHR, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.